Preparation and xenotransplantation of porcine islets
Patent Number: 7,122,177
Date of First Priority Issue: Thursday January 20th, 2000
Date Issued: Tuesday October 17th, 2006
Assignee: Diabcell PTY Ltd. (Parkside, AU)
Inventors: Elliott; Robert Bartlett (Auckland, NZ), Calafiore; Riccardo (Perugia, IT), Basta; Gusseppe (Perugia, IT)
From Class: Use
Comments: No comments
This patent covers the use of xenogeneic islet cells derived from fetal or neonatal pigs -20 to +10 days after birth, treating the cells with nicotinamide, lignocaine and a quinolone antibiotic, in order to generate a population of cells that may be encapsulated and used for treatment of diabetes in a human.
View this patent on the USPTO website.
Added to StemCellPatents.com on Saturday November 11th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.